A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection | MicrobiomeTrials
A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection
CompletedPHASE3INTERVENTIONAL
Trial Details
Start: 2023-04-21Est. Completion: 2025-01-17
Enrollment target: 41 participants
Locations
Ferring Investigational Site, North Little Rock, Arkansas, United States
Ferring Investigational Site, Camarillo, California, United States
Ferring Investigational Site, Hamden, Connecticut, United States
Ferring Investigational Site, Idaho Falls, Idaho, United States
Ferring Investigational Site, Gurnee, Illinois, United States
Ferring Investigational Site, Shreveport, Louisiana, United States
Ferring Investigational Site, Plymouth, Minnesota, United States
Ferring Investigational Site, Rochester, Minnesota, United States
Ferring Investigational Site, Cleveland, Ohio, United States
Ferring Investigational Site, Oklahoma City, Oklahoma, United States
Ferring Investigational Site, Burke, Virginia, United States
Ferring Investigational Site, Madison, Wisconsin, United States
Other microbiome trials you might be interested in